DNA Traits · Reproductive biology
Natural menopause timing, TMEM150B marker
The age at which periods stop naturally.

What the research found
In the cited research, the G allele at rs11668344 was associated with earlier age at natural menopause in studied women.
- AA
- Later
- AG
- Middle
- GG
- Earlier
What the study found
In the study, each copy went with age at natural menopause about 0.42 years lower on average.
- Evidence
- Genome-wide association with independent replication
- Who was studied
- Women of European descent
The research behind this card was done only in women, so it is part of a report requested as female.
How common each genotype is
| Region | AALater | AGMiddle | GGEarlier |
|---|---|---|---|
| All regions2,504 people | 46% | 42% | 12% |
| Africa661 people | 39% | 48% | 13% |
| The Americas347 people | 36% | 48% | 15% |
| East Asia504 people | 80% | 19% | <1% |
| Europe503 people | 43% | 47% | 11% |
| South Asia489 people | 31% | 46% | 23% |
Among the 2,504 people of the 1000 Genomes Project, in five world regions. These percentages describe groups of people, never anyone’s chance of having a trait.
Through time
How often the studied letter was read in ancient people, era by era, in the region chosen.
| Before farmingbefore 6500 BC | 15%8 of 55 copies read |
|---|---|
| First farmers6500 to 3000 BC | 33%292 of 873 copies read |
| Bronze Age3000 to 1200 BC | 38%307 of 812 copies read |
| Iron Age and Antiquity1200 BC to AD 600 | 34%352 of 1,029 copies read |
| Middle AgesAD 600 to 1500 | 34%148 of 431 copies read |
| Today1000 Genomes | 34%344 of 1,006 copies |
Neanderthal and Denisovan genomes
- Altai Neanderthal
- No copies
- Vindija Neanderthal
- No copies
- Chagyrskaya Neanderthal
- No copies
- Denisovan
- No copies
Neanderthals and Denisovans carried the other letter, so this letter is younger than our split with them.
The marker
- Gene or region
- TMEM150B / BRSK1 region
- Marker
- rs11668344
- Location
- Chromosome 19 · GRCh37 55,833,664 · GRCh38 55,322,296
- Letters studied
- A and G, with G as the studied allele
A DNA Traits report reads this marker in your raw DNA file and shows which of the three genotypes is yours, with how common it is. It counts the copies of the studied allele; it does not measure the trait itself.
- Marker
- TMEM150B / BRSK1 region · rs11668344
- Location
- Chromosome 19 · GRCh37 55,833,664 · GRCh38 55,322,296
- Studied allele
- G
- Published statistic
- Replication beta -0.415 years per G allele (SE 0.048), P 2.65e-18, G frequency 0.36; discovery -0.416 (SE 0.03), P 5.94e-43, 38,968 women; combined -0.416 (SE 0.026), P 1.45e-59 (Stolk 2012 Table 1). Day 2015 Table 1: -0.41 (SE 0.02) per G, P 5.5e-85, 69,329 women (Table 1, rs11668344 row (region 19a), Replication line)
- 1000 Genomes Project phase 3, people with 0, 1 and 2 copies
- All regions 1149 / 1046 / 309 · Africa 256 / 320 / 85 · The Americas 126 / 168 / 53 · East Asia 403 / 97 / 4 · Europe 214 / 234 / 55 · South Asia 150 / 227 / 112
What it cannot tell you
Studied in women of European descent and concerns natural menopause, not menopause after surgery or treatment. A single marker, one of about 290 linked to the age at natural menopause.
Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways (Stolk et al., 2012)More in Reproductive biology
- First period timing association
- Natural menopause timing association
- Fraternal twinning association
- Total testosterone association in men
- SHBG association
- FSH regulation association in men
- DHT research association in older men
- Fraternal twinning, SMAD3 marker
- Natural menopause timing, TDRD3 marker
- Natural menopause timing, UIMC1 marker
- Natural menopause timing, ASH2L marker
- First period timing, 9q31 marker
- First period timing, MKL2 marker
- Voice breaking timing, LIN28B marker
- Voice breaking timing, MKL2 marker
- Voice breaking timing, JHY marker
- Voice breaking timing, 9q31 marker
See your own two letters.
Upload the raw DNA file you already have. Your report reads this marker and every other card studied for you, each with its evidence and its limits.